Prevention of radiocontrast‐induced nephropathy

@article{Baker2003PreventionOR,
  title={Prevention of radiocontrast‐induced nephropathy},
  author={C. Baker},
  journal={Catheterization and Cardiovascular Interventions},
  year={2003},
  volume={58}
}
  • C. Baker
  • Published 2003
  • Medicine
  • Catheterization and Cardiovascular Interventions
An estimated 6,000 per million coronary angiograms and 2,000 per million angioplasties are carried out annually in Western countries, equating to 2.3 million cardiac-related doses of radiocontrast media per year in the United States alone. It is therefore not surprising that radiocontrast-induced nephropathy (RCIN) currently represents the third most common cause of in-hospital acute renal failure after hypotension and surgery [1]. The nature of this disorder makes it an attractive subject for… Expand

Topics from this paper

Prevention of radiocontrast nephropathy
TLDR
Available evidence indicates that several hours of intravenous pre-hydration is protective against contrast nephropathy and some studies suggest that oral N-acetylcysteine administration adds to this protection; further research is needed, however, with agents that can be administered immediately prior to contrast administration. Expand
Prevention of radiocontrast-induced nephropathy
TLDR
This issue of Cardiology Rounds comprehensively reviews recent studies and outlines recommended strategies for prevent- ing RCIN in patients with chronic renal insufficiency prior to coronary angiography and PCI. Expand
Bench-to-bedside review: Preventive measures for contrast-induced nephropathy in critically ill patients
TLDR
Administration of N-acetylcysteine, preferentially orally, or theophylline intravenously, next to hydration with bicarbonate solutions is advised, based on the available evidence. Expand
Prevention of contrast media-induced nephrotoxicity after angiographic procedures.
  • S. Morcos
  • Medicine
  • Journal of vascular and interventional radiology : JVIR
  • 2005
TLDR
If administration of iodinated contrast medium is deemed necessary in patients at high risk of CN, volume expansion should be offered and the lowest possible dose of nonionic isosmolar dimeric or nonionic low-OSmolar monomeric contrast medium should be used. Expand
Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography
TLDR
Elect evaluation of CIN in diabetic and nondiabetic patients with normal renal function undergoing coronary angiography found that diabetic patients without diabetic nephropathy and also patients without DM who hadnormal renal function are also at risk of contrast nephrophropathy. Expand
The Role of Extracorporeal Blood Purification Therapies in the Prevention of Radiocontrast-Induced Nephropathy
TLDR
Periprocedural extracorporeal blood purification does not reduce the incidence of RCIN compared with standard medical therapy, and the potential benefit of continuous venovenous hemofiltration published by a single center should be confirmed with further studies before it can be recommended or disregarded. Expand
A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.
TLDR
In this large, randomized trial, enrolling a high-risk group of patients with impaired renal function, intravenous NAC was ineffective in preventing CIN. Expand
The role of dialysis in contrast-induced nephropathy: doubts and certainties
TLDR
The role of dialysis in preventing contrast-induced nephropathy as well as present indications to its use in patients already on dialysis treatment undergoing diagnostic or therapeutic procedures with contrast medium injection are discussed. Expand
N‐acetylcysteine prophylaxis significantly reduces the risk of radiocontrast‐induced nephropathy: Comprehensive meta‐analysis
TLDR
Assessment of the overall effect of N‐acetylcysteine (NAC) in preventing radiocontrast‐induced nephropathy (RCIN) using all available data in the literature found that prophylaxis with NAC significantly reduces the risk for RCIN. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 81 REFERENCES
Radiocontrast induced nephropathy.
  • J. Lindholt
  • Medicine
  • European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
  • 2003
TLDR
The present research is unfortunately characterised by small numbers, lack of clinical important renal failure, and lack of long term results, but the latter may be important after new data indicate that radiation may trigger a chronic oxidative process through a similar pathway. Expand
Prevention of contrast nephropathy after cardiac catheterisation
TLDR
The incidence of RCIN is likely to be higher following interventional procedures than after angiography alone but is certainly not confined to the former. Expand
Use of fenoldopam to prevent radiocontrast nephropathy in high‐risk patients
TLDR
In this preliminary experience, the use of fenoldopam in high‐risk patients appears to minimize the likelihood of radioncontrast nephropathy. Expand
Potential deleterious effect of furosemide in radiocontrast nephropathy.
TLDR
Furosemide may be deleterious in the prevention of radiocontrast nephropathy, and weight loss was associated with weight loss in the furosemid-treated group. Expand
Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction.
TLDR
This study examined the renal hemodynamic effects of CM in patients at high risk of RCIN and related those effects to the subsequent development of RCIn, and confirmed that RCIN developed in six patients (50%) within 48 hours. Expand
Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.
TLDR
Prophylactic oral administration of the antioxidant acetylcysteine, along with hydration, prevents the reduction in renal function induced by contrast agents in patients with chronic renal insufficiency. Expand
Analysis of Radiocontrast-Induced Nephropathy by Dual-Labeled Radionuclide Clearance
TLDR
Persistent deterioration in renal function after radiocontrast administration appears to be dose-dependent and is not prevented by the use of ATP-MgCl2. Expand
Does Post-angiographic Hemodialysis Reduce the Risk of Contrast-medium Nephropathy?
TLDR
The risk of a marked and sustained reduction in renal function after administration of an iodine contrast medium is low with modern angiographic techniques, and the incidence of contrast-medium-induced nephrotoxicity is low. Expand
Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy.
TLDR
Administration of intravenous anaritide before and during a radiocontrast study did not reduce the incidence of RCIN in patients with preexisting chronic renal failure, with or without diabetes mellitus. Expand
Contrast-induced nephrotoxicity: the effects of vasodilator therapy.
TLDR
The aim of this prospective study was to identify those patients at greater risk of developing CIN and to evaluate the efficacy of vasodilator therapy with dopamine in limiting this complication. Expand
...
1
2
3
4
5
...